2019
Ovarian Teratomas in Women With Anti-N-methyl-D-Aspartate Receptor Encephalitis
Nolan A, Buza N, Margeta M, Rabban JT. Ovarian Teratomas in Women With Anti-N-methyl-D-Aspartate Receptor Encephalitis. The American Journal Of Surgical Pathology 2019, 43: 949-964. PMID: 31021857, DOI: 10.1097/pas.0000000000001249.Peer-Reviewed Original ResearchConceptsNeuroglial tissueLymphoid aggregatesControl teratomasGross pathologic featuresGerminal centersReceptor encephalitisPathologic featuresOvarian teratomaAnti-N-Methyl-D-Aspartate Receptor EncephalitisD-aspartate receptor encephalitisDiffuse inflammatory infiltrateImmune cell populationsMature cystic teratomaGeneration of autoantibodiesCell populationsCentral nervous systemGanglion cell clustersAssociated teratomaIncidental oophorectomyOvarian specimenAsymptomatic womenAutoimmune syndromeInflammatory infiltrateCystic teratomaAstrocyte population
2017
Ovarian Sertoli-Leydig cell tumors: a single institution experience and review of the literature.
Gressel G, Buza N, Pal L. Ovarian Sertoli-Leydig cell tumors: a single institution experience and review of the literature. European Journal Of Gynaecological Oncology 2017, 38: 214-220. PMID: 29953783.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAgedAged, 80 and overAntineoplastic Combined Chemotherapy ProtocolsChemotherapy, AdjuvantDisease-Free SurvivalFemaleHumansHyperandrogenismHysterectomyMiddle AgedNeoadjuvant TherapyNeoplasm GradingOvarian NeoplasmsOvariectomyPostmenopauseRetrospective StudiesSalpingectomySertoli-Leydig Cell TumorConceptsSertoli-Leydig cell tumorOvarian Sertoli-Leydig cell tumorPresent patient populationDisease-free survivalSingle institution experienceTertiary care institutionTime of diagnosisOnset of menopauseRisk of recurrenceSeries of casesAdjuvant chemotherapyMedian followPostmenopausal bleedingPostmenopausal patientsMedian ageMedian intervalClinical presentationDefinitive managementPathological findingsRetrospective reviewInstitution experiencePatient populationTreatment modalitiesCell tumorsTumor grade